Skip to main content
. 2020 Jun 30;2020:5120230. doi: 10.1155/2020/5120230

Figure 4.

Figure 4

Schematic representation of some recent and interesting combinations regarding ChEs and BACE-1 inhibitors and/or other targets involved in AD. Beside the dual action on the selected systems, most of the newly developed analogues have the potential to affect Aβ peptide aggregation along with oxidative stress and metal dyshomeostasis.